Exchange Traded (EEUE) - Trades

Play Episode

3min

Proactive - Interviews for investors

Solvonis Therapeutics strengthens board with addition of Dr Renata Crome

Solvonis Therapeutics PLC (LSE:SVNS) non-executive director-elect Dr Renata Crome talked with Proactive about her appointment to the board and what she brings to the company. Dr Crome has an extensive background in pharmaceutical development, having worked at Roche for 30 years. She played a key role in the development of blockbuster treatments such as bevacizumab and obinutuzumab for cancer, as well as Tamiflu for influenza. Following her time at Roche, she transitioned to board roles across commercial and charity organisations and also lectures in pharmaceutical medicine. Discussing her contributions to Solvonis, Dr Crome highlighted her strategic expertise and experience in central nervous system (CNS) treatments. "I have extensive experience in developing treatments in the central nervous system area, and I know the challenges and some of the solutions," she said. She also emphasised her ability to leverage a strong network of experts to support the company's goals. Dr Crome expressed enthusiasm for Solvonis' innovative pipeline and differentiated treatments, as well as the strength of its leadership team. "It’s a privilege to be invited to join them," she said. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #SolvonisTherapeutics #Pharmaceuticals #Biotech #HealthcareInnovation #Leadership #CNSResearch #DrugDevelopment #Investing #Biopharma #ExecutiveLeadership

Proactive - Interviews for investors

Daniel Tillett on Race Oncology’s drug advancements

Race Oncology Ltd CEO and managing director Daniel Tillett talked with Proactive about the company’s development of a reformulated cancer drug aimed at improving chemotherapy treatment. Tillett discussed the challenges of chemotherapy, including severe side effects, and how Race Oncology is working to minimise these risks while enhancing treatment effectiveness. He explained that the company has taken an older, previously approved drug and developed a new formulation that improves its delivery while protecting patients from heart-related side effects. This new approach, which involves combining the reformulated drug with anthracyclines, aims to enhance cancer treatment while reducing long-term health risks for patients. Tillett highlighted the significant market potential for the company’s drug, given that anthracyclines remain a cornerstone of cancer treatment. The company is now advancing into clinical trials, with results expected to provide key insights into the drug’s effectiveness in humans. Watch the full interview to learn more about Race Oncology’s latest advancements. Don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for more updates on cutting-edge biotech developments. #RaceOncology #CancerTreatment #Biotech #Chemotherapy #Pharmaceuticals #DrugDevelopment #ClinicalTrials #OncologyResearch #Investing #CancerResearch #Cardioprotection

Proactive - Interviews for investors

Titan Minerals: new high-grade gold drill results

Titan Minerals Ltd CEO Melanie Leighton talked with Proactive about the latest drilling results at the Dynasty Gold Project in southern Ecuador. The company has reported strong extensional drill results, indicating significant growth potential, with mineralisation extending up to 150 metres below the current resource. One standout result includes 17.5 metres at 2.5 g/t gold and 8.6 g/t silver, with a high-grade section of 5 metres at 5.5 g/t gold and 10.7 g/t silver. Leighton highlighted that these results validate Titan’s strategy, confirming that the Dynasty gold system has substantial expansion potential. "Hole CVDD24-122 has been an incredibly successful hole for us," she said. "It has delivered multiple significant intersections from shallow depths while also highlighting the presence of wide, high-grade mineralisation at depth." Titan’s drilling campaign continues at Cerro Verde and other key targets, with assay results pending from several drill holes. Despite temporary weather-related delays, the company remains on track for a Mineral Resource estimate update in mid-2025. For more updates on Titan Minerals’ progress, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe to the channel, and turn on notifications for future updates. #TitanMinerals #ASX #ProactiveInvestors #GoldMining #DynastyGoldProject #MiningNews #Investing #GoldExploration #ResourceExpansion #DrillResults #EcuadorMining #MiningUpdates

Proactive - Interviews for investors

Helix Exploration expands with key acquisition at Rudyard

HeLIX Exploration PLC (AIM:HEX) CEO Bo Sears talked with Proactive's Stephen Gunnion about the company’s latest expansion at its Rudyard Project in Montana. Sears highlighted the acquisition of the Weil #1 well and its surrounding 640-acre section, which effectively doubles Helix's production capacity. The purchase, completed for $300,000, presents significant value compared to the estimated $1.3 million cost of drilling a new well. Sears explained that Rudyard’s helium potential has been known since Texaco’s 1960 drilling, but only recently has its full scale been realised. With ongoing development, Helix is transitioning from an exploration-focused approach to a development drilling program, significantly reducing risks in future wells. The company is also preparing to spud the Linda #1 well in April, pending regulatory approvals. Additionally, Sears confirmed that the Darwin #1 well is ready for production as soon as the necessary plant infrastructure is in place. On the Ingomar project, he noted that while initial gas samples were noncommercial, future drilling in the Flathead formation is planned after environmental restrictions lift in mid-June. Stay tuned to Proactive for more updates from Helix Exploration. If you found this video helpful, give it a like, subscribe to our channel, and turn on notifications for future updates. #Helium #HelixExploration #EnergySector #OilAndGas #Drilling #Investment #NaturalResources #EnergyStocks #Montana #Exploration #Mining #StockMarket

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Exchange Traded Fund (EEUE)

Latest EEUE Trades
Delayed by 15 mins

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Exchange Traded Fund (EEUE) Trades

Exchange Traded Fund (EEUE)

🔥 Trades (Time & Sales) features

Latest EEUE Trades Delayed by 15 mins

Your Recent History

Go Ad-Free

Latest EEUE Trades
Delayed by 15 mins